High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance.
暂无分享,去创建一个
N Leigh Anderson | N. Anderson | G. Hortin | Glen L Hortin | Denis Sviridov | N. L. Anderson | D. Sviridov | N. Anderson | Glen L Hortin
[1] Fang Wang,et al. The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two‐dimensional electrophoresis gels and identification of 325 distinct proteins , 2003, Proteomics.
[2] B. Davis,et al. LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer , 2007 .
[3] D. Herold,et al. Immunoaffinity separation of plasma proteins by IgY microbeads: Meeting the needs of proteomic sample preparation and analysis , 2005, Proteomics.
[4] F. Vivanco,et al. Depletion of high-abundance proteins in plasma by immunoaffinity subtraction for two-dimensional difference gel electrophoresis analysis. , 2007, Methods in molecular biology.
[5] Gilbert S Omenn,et al. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: Systematic variation between sample types and calibration of mass spectrometry data , 2005, Proteomics.
[6] J. Brand,et al. Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion column , 2006, Proteomics.
[7] J. Kropf,et al. Evaluation of Cellular Fibronectin Plasma Levels as a Useful Staging Tool in Different Stages of Transitional Cell Carcinoma of the Bladder and Renal Cell Carcinoma , 2007, Biomarker insights.
[8] F. Putnam. 2 – Alpha, Beta, Gamma, Omega — The Roster of the Plasma Proteins , 1975 .
[9] S. Soldin,et al. Pediatric Reference Intervals , 2005 .
[10] Edward R. Ashwood,et al. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics , 2005 .
[11] W. Barrett,et al. Differences among techniques for high‐abundant protein depletion , 2005, Proteomics.
[12] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[13] N. Anderson,et al. Multi‐component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome , 2003, Proteomics.
[14] Ronald G. Tompkins,et al. High Dynamic Range Characterization of the Trauma Patient Plasma Proteome*S , 2006, Molecular & Cellular Proteomics.
[15] S. Hanash,et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study , 2006, Nature Biotechnology.
[16] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[17] Graham B. I. Scott,et al. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.
[18] Leigh Anderson,et al. Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.
[19] R. Bookman,et al. The plasma proteins. , 1947, Annals of western medicine and surgery.
[20] T. Peters,et al. Plasma protein secretion by the liver , 1983 .
[21] Denis Hochstrasser,et al. Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. , 2006, American heart journal.
[22] S. Kern,et al. Quality control of serum albumin depletion for proteomic analysis. , 2007, Clinical chemistry.
[23] G. Hortin. A new era in protein quantification in clinical laboratories: application of liquid chromatography-tandem mass spectrometry. , 2007, Clinical Chemistry.
[24] George G Klee,et al. LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer. , 2007, Clinical chemistry.
[25] G. Lippi,et al. Lipoprotein(a): Structure, Measurement and clinical significance. , 1994 .
[26] Amos Bairoch,et al. Plasma and red blood cell protein maps: Update 1993 , 1993, Electrophoresis.
[27] Simon C. F. Sheng,et al. Multidimensional Liquid Chromatography Separation of Intact Proteins by Chromatographic Focusing and Reversed Phase of the Human Serum Proteome , 2006, Molecular & Cellular Proteomics.
[28] Ronald J. Moore,et al. Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.
[29] G. Cagney,et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.
[30] C. Bladon,et al. 5 Amino acids, peptides and proteins , 1993 .
[31] T. Veenstra,et al. The Human Plasma Proteome , 2004, Molecular & Cellular Proteomics.
[32] G. Hortin. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. , 2006, Clinical chemistry.
[33] M. Uhlén. Mapping the human proteome using antibodies. , 2007, Molecular & cellular proteomics : MCP.
[34] D. Hochstrasser,et al. Industrial‐scale proteomics: From liters of plasma to chemically synthesized proteins , 2004, Proteomics.
[35] Fuchu He,et al. Different immunoaffinity fractionation strategies to characterize the human plasma proteome. , 2006, Journal of proteome research.
[36] Hong Wang,et al. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system , 2005, Proteomics.
[37] G. Hortin,et al. Mass determination of major plasma proteins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry , 2006, Clinical Proteomics.
[38] N. Anderson,et al. A List of Candidate Cancer Biomarkers for Targeted Proteomics , 2006, Biomarker insights.
[39] D. Chan,et al. Proteomics: a new diagnostic frontier. , 2006, Clinical chemistry.
[40] Nader Rifai,et al. Handbook of Lipoprotein Testing , 2001 .
[41] Ronald J. Moore,et al. Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.